# Repeated Neurocognitive Measurements in Depressed Patients

> **NCT05991232** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Jay Fournier**

## Conditions studied

- Depression, Unipolar

## Interventions

- **DRUG:** Intravenous Ketamine

## Key facts

- **NCT ID:** NCT05991232
- **Lead sponsor:** Jay Fournier
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-05-01
- **Primary completion:** 2028-04
- **Final completion:** 2029-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study never started enrollment at this site. Delays in establishing the infrastructure for this project resulted in the funds no longer being available at this time. Should additional funds be secured, a separate study will be registered here.
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05991232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05991232, "Repeated Neurocognitive Measurements in Depressed Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05991232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*